Osborne CK - Search Results

1

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC, Wong H, Rosen J, Chang JC. Li X, et al. Among authors: osborne ck. J Natl Cancer Inst. 2008 May 7;100(9):672-9. doi: 10.1093/jnci/djn123. Epub 2008 Apr 29. J Natl Cancer Inst. 2008. PMID: 18445819

2

Chemotherapy versus observation in high-risk node-negative breast cancer patients.

Mansour EG, Eudey L, Tormey DC, Shatila AH, Osborne CK, Gilchrist KW, Cooper MR, Falkson G. Mansour EG, et al. Among authors: osborne ck. J Natl Cancer Inst Monogr. 1992;(11):97-104. J Natl Cancer Inst Monogr. 1992. PMID: 1627437 Clinical Trial.

3

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

Osborne CK, Coronado E, Allred DC, Wiebe V, DeGregorio M. Osborne CK, et al. J Natl Cancer Inst. 1991 Oct 16;83(20):1477-82. doi: 10.1093/jnci/83.20.1477. J Natl Cancer Inst. 1991. PMID: 1920493

4

Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.

Hanauske AR, Osborne CK, Chamness GC, Clark GM, Forseth BJ, Buchok JB, Arteaga CL, Von Hoff DD. Hanauske AR, et al. Among authors: osborne ck. Eur J Cancer Clin Oncol. 1987 May;23(5):545-51. doi: 10.1016/0277-5379(87)90318-x. Eur J Cancer Clin Oncol. 1987. PMID: 3498632

5

Multiple estrogen receptor assays in human breast cancer.

Hull DF 3rd, Clark GM, Osborne CK, Chamness GC, Knight WA 3rd, McGuire WL. Hull DF 3rd, et al. Among authors: osborne ck. Cancer Res. 1983 Jan;43(1):413-6. Cancer Res. 1983. PMID: 6847780

6

Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.

Osborne CK, Coronado-Heinsohn EB, Hilsenbeck SG, McCue BL, Wakeling AE, McClelland RA, Manning DL, Nicholson RI. Osborne CK, et al. J Natl Cancer Inst. 1995 May 17;87(10):746-50. doi: 10.1093/jnci/87.10.746. J Natl Cancer Inst. 1995. PMID: 7563152

7

Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, Osborne CK, Waldman FM. Isola JJ, et al. Among authors: osborne ck. Am J Pathol. 1995 Oct;147(4):905-11. Am J Pathol. 1995. PMID: 7573366 Free PMC article.

8

Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression.

Reddy KB, Yee D, Hilsenbeck SG, Coffey RJ, Osborne CK. Reddy KB, et al. Among authors: osborne ck. Cell Growth Differ. 1994 Dec;5(12):1275-82. Cell Growth Differ. 1994. PMID: 7696176

9

Translational research in the San Antonio breast cancer SPORE.

Osborne CK, Chamness GC. Osborne CK, et al. Breast Cancer Res Treat. 1994;32(1):1-4. Breast Cancer Res Treat. 1994. PMID: 7819578 No abstract available.

10

Prognostic factors: rationale and methods of analysis and integration.

Clark GM, Hilsenbeck SG, Ravdin PM, De Laurentiis M, Osborne CK. Clark GM, et al. Among authors: osborne ck. Breast Cancer Res Treat. 1994;32(1):105-12. doi: 10.1007/BF00666211. Breast Cancer Res Treat. 1994. PMID: 7819579 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters